KGA-2727
CAS: 666842-36-0
Ref. TM-T15656
| 1mg | 131.00 € | ||
| 2mg | 180.00 € | ||
| 5mg | 271.00 € | ||
| 10mg | 449.00 € | ||
| 25mg | 740.00 € | ||
| 50mg | 1,013.00 € | ||
| 100mg | 1,388.00 € | ||
| 1mL*10mM (DMSO) | 318.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Product Information
Name:
KGA-2727
Synonyms:
- 3-[[3-[4-[[3-(β-D-Glucopyranosyloxy)-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-3-methylphenoxy]propyl]amino]propanamide
- Propanamide, 3-[[3-[4-[[3-(β-D-glucopyranosyloxy)-5-(1-methylethyl)-1H-pyrazol-4-yl]methyl]-3-methylphenoxy]propyl]amino]-
- KGA 2727
Description:
KGA-2727: potent, selective SGLT1 inhibitor (human Ki 97.4 nM, rat 43.5 nM), with high selectivity over SGLT2 for diabetes treatment.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
536.62
Formula:
C26H40N4O8
Purity:
98.95%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T15656 KGA-2727
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
